Dr. Tamar Tennenbaum is the founder and CEO of Arava Bio-Tech, Ltd and Chief Scientific Officer at OneGuild Institute (also known as Peter Sheehan Diabetes Care Foundation). A physician–scientist and established biotech entrepreneur, she specializes in the discovery and development of innovative therapeutics in wound healing, oncology, and dermatology. Dr. Tennenbaum holds an MD and a PhD in cell biology and pharmacology from the Hebrew University–Hadassah Medical School in Jerusalem, Israel. She has led the successful translation of advanced drug candidates from preclinical research to Phase 3 clinical trials and is the author of more than 50 scientific publications and book chapters.